6533b858fe1ef96bd12b6271

RESEARCH PRODUCT

469: Prospective, randomized, multicenter trial comparing conversion to a CNI-free regimen (MMF & sirolimus) vs. a CNI-reduced, MMF-based immunosuppression to improve renal function in late cardiac transplant recipients

C. SchmidJ. SchirmerH. WelpThorsten WittwerK. KaiserBruno MeiserHae-young SohnBruno ReichartM. VossIngo KaczmarekEmilia StegemannUwe SchulzThorsten WahlersJan Groetzner

subject

Pulmonary and Respiratory MedicineTransplantationmedicine.medical_specialtybusiness.industrymedicine.medical_treatmentUrologyRenal functionImmunosuppressionRegimenMulticenter trialSirolimusmedicineSurgeryCardiology and Cardiovascular Medicinebusinessmedicine.drughttps://doi.org/10.1016/j.healun.2006.11.492